Optimization Rights. During the Research Period, Solvay may submit any Licensed Compound Set to ArQule for optimization in the Directed Array Program; however, ArQule has no obligation to increase its commitment to the Directed Array Program as set forth in Section 4.3. At any time, Solvay may conduct optimization of any Licensed Compound Set. In the event that Solvay conducts optimization of a Licensed Compound Set, then at the request of Solvay, ArQule will provide Solvay with synthetic protocols (in American Chemical Society experimental format, not automated protocols) to enable Solvay to make those Licensed Compounds.
Appears in 2 contracts
Sources: Research, Development and License Agreement (Arqule Inc), Research, Development and License Agreement (Arqule Inc)